ADA

Gene Information
 
Gene Symbol
ADA
 
Aliases
-
 
Entrez Gene ID
100
 
Gene Name
Adenosine deaminase
 
Chromosomal Location
20q13.12
 
HGNC ID
 
Summary
This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0001666 Biological process Response to hypoxia IDA 16670267
GO:0006154 Biological process Adenosine catabolic process IBA 21873635
GO:0006154 Biological process Adenosine catabolic process IDA 8894685, 16670267
GO:0032261 Biological process Purine nucleotide salvage IMP 9361033
GO:0033632 Biological process Regulation of cell-cell adhesion mediated by integrin IDA 11772392
Protein Information
 
Protein Name
Adenosine deaminase, adenosine aminohydrolase
 
Function
Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine (PubMed:8452534, PubMed:16670267). Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4 (PubMed:20959412). Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion (PubMed:11772392). Enhances dendritic cell immunogenicity by affecting dendritic cell costimulatory molecule expression and cytokines and chemokines secretion (By similarity). Enhances CD4+ T-cell differentiation and proliferation (PubMed:20959412). Acts as a positive modulator of adenosine receptors ADORA1 and ADORA2A, by enhancing their ligand affinity via conformational change (PubMed:23193172). Stimulates plasminogen activation (PubMed:15016824). Plays a role in male fertility (PubMed:21919946, PubMed:26166670). Plays a protective role in early postimplantation embryonic development (By similarity).
 
Refseq Proteins
 
UniProt
 
PDB
 
Pfam
Pfam Accession Pfam ID
PF00962 A_deaminase
Pathways
 
KEGG
 
Reactome
 

Purine metabolism
Metabolic pathways
Primary immunodeficiency

 

Purine salvage

Interactions
 
STRING MINT IntAct
ENSP00000458832 P16050
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Cardiovascular Diseases
Hyperemia
Endocrine System Diseases
PCOS
Immune System Diseases
SCID
ADA Deficiency
Neoplasms
Pancreatic Ductal Adenocarcinoma
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
ADA2 
PCOS 
G22A, A4223C  
 
Direct 
200 PCOS control patients and 200 healthy women 
The results of the present study showed that serum total adenosine deaminase catalytic activity (tADA) as well as ADA1, and ADA2 enzyme activities were significantly reduced in PCOS compared to control healthy women. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412